What is the Future of MS Therapy? Neuroprotection, and Blurred Lines Between Disease Phenotypes

Stuart SchlossmanMS Drug Therapies, Multiple Sclerosis

When Ben Greenberg, MD,
MPH, was asked to present a talk for the 2020 Consortium of Multiple Sclerosis
Centers (CMSC) Virtual Annual Meeting on “Emerging Therapies Across the
Spectrum of Disease,” he got to thinking about what this “spectrum”
means, and how it affects the future of multiple sclerosis (MS) treatment.



 Read More…

Click HERE to Subscribe for the MS Beacon Newsletter

::::::::::::::::::::::::::::::::::::::;;;;;;;;;;;;;;;;;;;;;::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
Information Shared by: MSViewsandNews
to and for those affected by Multiple Sclerosis
::::::::::::::::::::::::::::::::::::::;;;;;;;;;;;;;;;;;;;;;:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::


Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews